Immune efficacy of first and repeat trivalent influenza vaccine in healthy subjects and hemodialysis patients

Advances in Experimental Medicine and Biology

Volumn 836, Issue , 2015, Pages 47-54

  Mastalerz Migas, Agnieszka ^a,b   Bujnowska Fedak, Maria ^a   Brydak, Lidia B ^c,d  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b OPOLE MEDICAL SCHOOL   (Poland)

^c NATIONAL MEDICINES INSTITUTE   (Poland)

^d UNIVERSITY OF SZCZECIN   (Poland)

Author keywords

Hemagglutinin; Hemodialysis; Influenza; Vaccination

Indexed keywords

ANTIBODY; HEMAGGLUTININ ANTIBODY; INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IMMUNE RESPONSE; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CODING; PRIMARY HEALTH CARE; ACTIVE IMMUNIZATION; AGED; CONTROLLED CLINICAL TRIAL; IMMUNIZATION; IMMUNOLOGY; INFLUENZA, HUMAN; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NORMAL HUMAN; RENAL REPLACEMENT THERAPY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VACCINATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IMMUNITY, ACTIVE; IMMUNIZATION, SECONDARY; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; TREATMENT OUTCOME; VACCINATION;

EID: 84912003579     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/5584_2014_36     Document Type: Article

References (19)

1. ACIP-Advisory Committee on Immunization Practices (2011) Recommendations of the prevention and control of influenza with vaccines. MMWR Morb Mortal Wkly Rep 60:11-28
2. Antonen JA, Hannula PM, Pyhälä R, Saha HH, Ala-Houhala IO, Pasternack AI (2000) Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 86(1):1402-1412
3. Beyer WE, Versluis DJ, Kramer P, Diderich PP, Weimar W, Masurel N (1987) Trivalent influenza vaccine in patients on hemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components. Vaccine 5(1):43-48
4. Beyer WE, Palache AM, Lüchters G, Nauta J, Osterhaus AD (2004) Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res 103(1-2):125-132
5. Brydak LB (2008) Influenza, pandemic flu myth or a real threat? Rhythm, 1st edn (in Polish), Warsaw
6. Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T (2003) The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 37(1):71-76
7. Cohen G, Hörl WH (2012) Immune dysfunction in uremia-an update. Toxins 4(11):962-999
8. Eiselt J, Kielberger L, Sedláčková T, Racek J, Pazdiora P (2010) High ferritin, but not hepcidin, is associated with a poor immune response to an influenza vaccine in hemodialysis patients. Nephron Clin Pract 115(2):147-153
9. EMA-European Medicines Agency, Committee for Proprietary Medicinal Products (1997) Note for guidance on harmonisation of requirements for influenza vaccines. CPMP/BWP/214/96. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003945.pdfł. Accessed 30 Dec 2013
10. Kunisaki KM, Janoff EN (2009) Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality and vaccine responses. Lancet Infect Dis 9(8):493-504
11. Künzel W, Glathe H, Engelmann H, Van Hoecka C (1996) Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 14(12):1108-1110
12. Mastalerz-Migas A, Steciwko A, Brydak LB (2013) Immune response to influenza vaccine in hemodialysis patients with chronic renal failure. Adv Exp Med Biol 756:285-290
13. Matsushita M, Takeuchi S, Kumagai N, Uehara Y, Matsushita C, Arise K, Seo H, Awatani T (2012) Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population. Vaccine 30 (6):1101-1107
14. Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, Rangarajan B, Newton DW, Boulton ML, Monto AS (2006) Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. New Engl J Med 355(24):2513-2522
15. Ott U, Sauerbrei A, Lange J, Schäfler A, Walther M, Wolf G, Wutzler P, Zell R, Krumbholz A (2012) Serological response to influenza A H1N1 vaccine (Pandemrix®) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients. Med Microbiol Immunol 201 (3):297-302
16. Sasaki S, He XS, Holmes TH, Dekker CL, Mahmood K, Kemble GW, Arvin AM, Greenberg HB (2007) Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 81(1):215-228
17. Sasaki S, He XS, Holmes TH, Dekker CL, Kemble GW, Arvin AM, Greenberg HB (2008) Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One 3(8):e2975
18. Vaziri ND, Pahl MV, Crum A, Norris K (2012) Effect of uremia on structure and function of immune system. J Ren Nutr 22(1):149-156
19. Vogtländer NPJ, Brown A, Valentijn RM, Rimmelzwaan GF, Osterhaus AD (2004) Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine 22(17-18): 2199-2201